← Every applicant
Bpi Labs FDA Approvals
5 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| TESTOSTERONE CYPIONATENew drugSep 3, 2026INJECTABLE, INJECTION |
| FLUORESCEIN SODIUMNew drugApr 30, 2026INJECTABLE, INTRAVENOUS |
| TRIMETHOBENZAMIDE HYDROCHLORIDENew drugOct 16, 2025INJECTABLE, INJECTION |
| NALOXONE HYDROCHLORIDENew drugOct 6, 2023INJECTABLE, INJECTION |
| MYCOPHENOLATE MOFETIL HYDROCHLORIDENew drugJun 1, 2023INJECTABLE, INJECTION |